Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nanosonics Limited ( (AU:NAN) ) just unveiled an update.
Pinnacle Investment Management Group Limited has become a substantial holder in Nanosonics Limited as of June 13, 2025, acquiring a 5.21% voting power through 15,812,969 ordinary fully paid shares. This acquisition signifies a notable investment in Nanosonics, potentially impacting its market positioning and signaling confidence in its future prospects.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products that focus on reducing the risk of infection in healthcare settings.
Average Trading Volume: 1,034,679
Technical Sentiment Signal: Buy
Current Market Cap: A$1.3B
See more insights into NAN stock on TipRanks’ Stock Analysis page.